Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

M

MBX

MBX Biosciences Inc

67.99

Aug 04 • 1:41 PM ET +3.58 (5.56%)

Healthcare Biotechnology USA Mid NASD

Peers: KYMR NUVL BMRN RYTM INCY KRYS VKTX AXSM MDGL NBIX

| Held by: VTI IWM IWO VXF XPH IBB VTWO FESM SCHA IWC

Scroll to Statements

Index	RUT
Market Cap	3.24B
Enterprise Value	2.80B
Income	-86.61M
Sales	0.00M
Book/sh	9.20
Cash/sh	9.24
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	63
IPO	Sep 13, 2024

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	7.39
P/C	7.36
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	30.79
Current Ratio	30.79
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-2.21
EPS next Y	-3.65
EPS next Q	-0.63
EPS this Y	-17.05%
EPS next Y	-31.05%
EPS next 5Y	-19.76%
EPS past 3/5Y	-44.91% -
Sales past 3/5Y	- -
EPS Y/Y TTM	-0.43%
Sales Y/Y TTM	-
EPS Q/Q	29.35%
Sales Q/Q	-
Earnings	May 07 BMO
EPS/Sales Surpr.	12.78% -

Insider Own	38.08%
Insider Trans	-0.29%
Inst Own	89.72%
Inst Trans	10.89%
ROA	-24.79%
ROE	-25.73%
ROIC	-19.77%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	9.53%
SMA50	38.02%
SMA200	91.64%
Trades

Shs Outstand	47.57M
Shs Float	29.47M
Short Float	19.60%
Short Ratio	6.79
Short Interest	5.78M
52W High	69.40 -2.03%
52W Low	9.63 606.02%
Volatility	6.78% 8.02%
ATR (14)	4.37
RSI (14)	65.73
Beta	0.09
Rel Volume	0.70
Avg Volume	850.18K
Volume	395,481

Perf Week	13.20%
Perf Month	17.83%
Perf Quarter	130.94%
Perf Half Y	74.02%
Perf YTD	115.57%
Perf Year	442.18%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.09
Target Price	80.40
Prev Close	64.41
Price	67.99
Change	5.56%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)